DarioHealth Corp. 8-K

What Happened
DarioHealth Corp. (DRIO) filed a Form 8-K on July 10, 2026 (Item 5.02) reporting that the temporary medical leave of Steven Nelson, the Company’s President and Chief Commercial Officer, was extended for an indefinite period. During Mr. Nelson’s absence, his responsibilities are being assumed by members of the Company’s senior management team.

Key Details

• Filing date: July 10, 2026 (Form 8-K, Item 5.02).
• Executive affected: Steven Nelson, President and Chief Commercial Officer.
• Status: Medical leave extended for an indefinite period.
• Interim coverage: Responsibilities are being handled by the Company’s senior management team; no interim replacement or permanent successor was named in the filing.

Why It Matters
This is a material executive-change disclosure about DarioHealth’s commercial leadership. For investors, changes in the company’s President/CCO role can affect go-to-market execution, sales oversight and, ultimately, revenue and quarterly results—especially if the absence is prolonged. The company indicates continuity by assigning duties to senior management, but investors should watch for future filings or announcements for updates on Mr. Nelson’s return, any interim appointments, or impacts to commercial strategy and guidance.